Exploring the combined neuroprotective effects of resveratrol and hesperidin in a scopolamine-induced rat model of cognitive impairment
- 26 May 2025
- journal article
- Published by Elsevier in Neuroscience
- Vol. 579, 54-68
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Combined resveratrol and vitamin D treatment ameliorate inflammation-related liver fibrosis, ER stress, and apoptosis in a high-fructose diet/streptozotocin-induced T2DM modelHistochemistry and Cell Biology, 2022
- Prophylactic administration of rosmarinic acid ameliorates depression‐associated cardiac abnormalities in Wistar rats: Evidence of serotonergic, oxidative, and inflammatory pathwaysJournal of Biochemical and Molecular Toxicology, 2022
- Protective effects of chlorogenic acid on isoflurane‐induced cognitive impairment of aged miceFood Science & Nutrition, 2022
- Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedsideMolecular Neurobiology, 2022
- Nobiletin prevents amyloid β1-40-induced cognitive impairment via inhibition of neuroinflammation and oxidative/nitrosative stressMetabolic Brain Disease, 2022
- Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic TargetNeurochemical Research, 2022
- Harmonizing neuropsychological assessment for mild neurocognitive disorders in EuropeAlzheimer's & Dementia, 2021
- Dissection of Rodent Brain Regions2011
- Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in ratsCancer Chemotherapy and Pharmacology, 2010
- Methods of microphotometric assay of succinate dehydrogenase and cytochromec oxidase activities for use on human skeletal muscleJournal of Molecular Histology, 1989